Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis

Nanomedicine

Volumn 11, Issue 7, 2016, Pages 833-849

  Posadas, Inmaculada ^a,b   Monteagudo, Silvia ^a,b   Ceña, Valentín ^a,b  

^a Universidad de Castilla La Mancha   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

blood brain barrier; brain; drug delivery; imaging; nanoparticles; siRNA

Indexed keywords

CARBON NANOTUBE; CHITOSAN NANOPARTICLE; DENDRIMER; GOLD NANOPARTICLE; LIPOSOME; NANOPARTICLE; POLYMER; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; DRUG CARRIER;

ANTIGENICITY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC IMAGING; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; GENE TARGETING; HUMAN; LIPID BILAYER; MACROMOLECULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TRANSCYTOSIS; ANIMAL; BRAIN; BRAIN DISEASES; DRUG EFFECTS; GENE TRANSFER; GENETICS; METABOLISM; NANOMEDICINE; NANOTECHNOLOGY; PATHOLOGY; PROCEDURES;

ANIMALS; BRAIN; BRAIN DISEASES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84962068350     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.16.15     Document Type: Review

References (106)

1. Hawkins MJ, Soon-Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev. 60(8), 876-885 (2008
2. Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein nanoparticles as drug Delivery carriers for cancer therapy. Biomed. Res. Int. 2014, 180549 (2014
3. Posadas I, Guerra FJ, Ceña V. Nonviral vectors for the Delivery of small interfering RNAs to the CNS. Nanomed. (Lond.) 5(8), 1219-1236 (2010
4. Simko M, Mattsson MO. Interactions between nanosized materials and the brain. Curr. Med. Chem. 21(37), 4200-4214 (2014
5. Doolittle ND, Muldoon LL, Culp AY, Neuwelt EA. Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances. Adv. Pharmacol. 71, 203-243 (2014
6. Xu G, Mahajan S, Roy I, Yong KT. Theranostic quantum dots for crossing blood-brain barrier in vitro and providing therapy of HIV-Associated encephalopathy. Front. Pharmacol. 4, 140 (2013
7. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7(1), 41-53 (2006
8. Shilo M, Motiei M, Hana P, Popovtzer R. Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications. Nanoscale. 6(4), 2146-2152 (2014
9. Demeule M, Currie JC, Bertrand Y, et al. Involvement of the low-Density lipoprotein receptor-related protein in the transcytosis of the brain Delivery vector angiopep-2. J. Neurochem. 106(4), 1534-1544 (2008
10. Malatesta M, Giagnacovo M, Costanzo M, et al. Diaminobenzidine photoconversion is a suitable tool for tracking the intracellular location of fluorescently labelled nanoparticles at transmission electron microscopy. Eur. J. Histochem. 56(2), e20 (2012
11. Peng YS, Lai PL, Peng S, et al. Glial cell line-Derived neurotrophic factor gene Delivery via a polyethylene imine grafted chitosan carrier. Int. J. Nanomed. 9, 3163-3174 (2014
12. Skop NB, CalDeron F, Levison SW, Gandhi CD, Cho CH. Heparin crosslinked chitosan microspheres for the Delivery of neural stem cells and growth factors for central nervous system repair. Acta Biomater. 9(6), 6834-6843 (2013
13. Nagpal K, Singh SK, Mishra DN. Nanoparticle mediated brain targeted Delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamineinduced amnesia. Drug Deliv. 20(3-4), 112-119 (2013
14. Ishii T, Asai T, Oyama D, et al. Treatment of Cerebral Ischemia-reperfusion Injury with PEGylated Liposomes Encapsulating FK506. FASEB J. 27(4), 1362-1370 (2012
15. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 1(3), 297-315 (2006
16. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 311(5761), 622-627 (2006
17. Wong HL, Chattopadhyay N, Wu XY, Bendayan R. Nanotechnology applications for improved Delivery of antiretroviral drugs to the brain. Adv. Drug Deliver. Rev. 62(4-5), 503-517 (2010
18. DeBoer AG, van Der Sandt IC, Gaillard PJ. The role of drug transporters at the blood-brain barrier. Annu. Rev. Pharmacol. Toxicol. 43, 629-656 (2003
19. Yusuf M, Khan M, Khan RA, Ahmed B. Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimers disease moDel. J. Drug Target. 21(3), 300-311 (2012
20. Gaur PK, Mishra S, Bajpai M, Mishra A. Enhanced oral bioavailability of efavirenz by solid lipid nanoparticles: in vitro drug release and pharmacokinetics studies. Biomed. Res. Int. 2014, 363404 (2014
21. Kuo YC, Wang CC. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain. Biotechnol. Prog. 30(1), 198-206 (2014
22. Sahay G, Querbes W, Alabi C, et al. Efficiency of siRNA Delivery by lipid nanoparticles is limited by endocytic recycling. Nat. Biotechnol. 31(7), 653-658 (2013
23. Frank RT, Aboody KS, Najbauer J. Strategies for enhancing antibody Delivery to the brain. Biochim. Biophys. Acta 1816(2), 191-198 (2011
24. Boado RJ, Pardridge WM. The Trojan horse liposome technology for nonviral gene transfer across the blood-brain barrier. J. Drug Deliv. 2011, 296151 (2011
25. Zabel MD. LipopeptiDeDelivery of siRNA to the central nervous system. Methods Mol. Biol. 948, 251-262 (2013
26. Savarala S, Brailoiu E, WunDer SL, Ilies MA. Tuning the self-Assembling of pyridinium cationic lipids for efficient gene Delivery into neuronal cells. Biomacromolecules. 14(8), 2750-2764 (2013
27. Zhong D, Jiao Y, Zhang Y, et al. Effects of the gene carrier polyethyleneimines on structure and function of blood components. Biomaterials. 34(1), 294-305 (2013
28. Lee CH, Kasala D, Na Y, et al. Enhanced therapeutic efficacy of an aDenovirus-PEI-bile-Acid complex in tumors with low coxsackie and aDenovirus receptor expression. Biomaterials. 35(21), 5505-5516 (2014
29. Zhang X, Oulad-AbDelghani M, Zelkin AN, et al. Poly(Llysine) nanostructured particles for gene Delivery and hormone stimulation. Biomaterials. 31(7), 1699-1706 (2010
30. Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. Drug Delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J. Control. Release. 93(2), 151-160 (2003
31. Ulery BD, Nair LS, Laurencin CT. Biomedical applications of bioDegradable polymers. J. Polym. Sci. B Polym. Phys. 49(12), 832-864 (2011
32. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extenDed circulation in blood and potential for systemic gene Delivery. Gene Ther. 6(4), 595-605 (1999
33. Nguyen HK, Lemieux P, Vinogradov SV, et al. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7(2), 126-138 (2000
34. Tang GP, Zeng JM, Gao SJ, et al. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. Biomaterials. 24(13), 2351-2362 (2003
35. Kolter M, Ott M, Hauer C, Reimold I, Fricker G. Nanotoxicity of poly(n-butylcyano-Acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo. J. Control. Release 197, 165-179 (2015
36. Frank RT, Aboody KS, Najbauer J. Strategies for enhancing antibody Delivery to the brain. Biochim. Biophys. Acta 1816(2), 191-198 (2011
37. Solev IN, Balabanyan VY, Volchek IA, et al. Involvement of BDNF and NGF in the mechanism of neuroprotective effect of human recombinant erythropoietin nanoforms. Bull. Exp. Biol. Med. 155(2), 242-244 (2013
38. Jiang X, Xin H, Sha X, et al. PEGylated poly(trimethylene carbonate) nanoparticles loaDed with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Int. J. Pharm. 420(2), 385-394 (2011
39. Klyachko NL, Manickam DS, Brynskikh AM, et al. Crosslinked antioxidant nanozymes for improved Delivery to CNS. Nanomedicine. 8(1), 119-129 (2012
40. Boylan NJ, Kim AJ, Suk JS, et al. Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine. Biomaterials. 33(7), 2361-2371 (2012
41. Gerson T, Makarov E, Senanayake TH, Gorantla S, Poluektova LY, Vinogradov SV. Nano-NRTIs Demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine. 10(1), 177-185 (2014
42. Ku B, Kim JE, Chung BH, Chung BG. Retinoic acidpolyethyleneimine complex nanoparticles for embryonic stem cell-Derived neuronal differentiation. Langmuir. 29(31), 9857-9862 (2013
43. Fornaguera C, Dols-Perez A, CalDero G, Garcia-Celma MJ, Camarasa J, Solans C. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug Delivery across the blood-brain barrier. J. Control. Release 211, 134-143 (2015
44. Jain A, Jain A, Garg NK, et al. Surface engineered polymeric nanocarriers mediate the Delivery of transferrin-methotrexate conjugates for an improved unDerstanding of brain cancer. Acta Biomater. 24, 140-151 (2015
45. Harrison J, Bartlett CA, Cowin G, et al. In vivo imaging and biodistribution of multimodal polymeric nanoparticles Delivered to the optic nerve. Small. 8(10), 1579-1589 (2012
46. Li J, Cai P, Shalviri A, et al. A multifunctional polymeric nanotheranostic system Delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer. ACS Nano. 8(10), 9925-9940 (2014
47. Tomalia DA, Baker H, Dewald J, et al. A new class of polymers - starburst-Dendritic macromolecules. Polym. J. 17(1), 117-132 (1985
48. Albertazzi L, Gherardini L, Brondi M, et al. In vivo distribution and toxicity of PAMAM Dendrimers in the central nervous system Depend on their surface chemistry. Mol. Pharm. 10(1), 249-260 (2013
49. Tomalia DA, Christensen JA, Boas U. Dendrimers, Dendrons and Dendritic polymers. Cambridge University Press, UK, ISBN: 9760521515801 (2012
50. Perez-Martinez FC, Guerra J, Posadas I, Ceña V. Barriers to non-viral vector-mediated gene Delivery in the nervous system. Pharm. Res. 28(8), 1843-1858 (2011
51. Shcharbin D, Janaszewska A, Klajnert-Maculewicz B, et al. How to study Dendrimers and Dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo. J. Control. Release 181, 40-52 (2014
52. Lesniak WG, Mishra MK, Jyoti A, et al. Biodistribution of fluorescently labeled PAMAM Dendrimers in neonatal rabbits: effect of neuroinflammation. Mol. Pharm. 10(12), 4560-4571 (2013
53. Mishra MK, Beaty CA, Lesniak WG, et al. Dendrimer brain uptake and targeted therapy for brain injury in a large animal moDel of hypothermic circulatory arrest. ACS Nano. 8(3), 2134-2147 (2014
54. Gao X, Qian J, Zheng S, et al. Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect. Pharm. Res. 30(10), 2538-2548 (2013
55. Nyitrai G, Heja L, Jablonkai I, Pal I, Visy J, Kardos J. Polyamidoamine Dendrimer impairs mitochondrial oxidation in brain tissue. J. Nanobiotechnol. 11, 9 (2013
56. Wang S, Li Y, Fan J, et al. The role of autophagy in the neurotoxicity of cationic PAMAM Dendrimers. Biomaterials. 35(26), 7588-7597 (2014
57. Naha PC, Byrne HJ. Generation of intracellular reactive oxygen species and genotoxicity effect to exposure of nanosized polyamidoamine (PAMAM) Dendrimers in PLHC-1 cells in vitro. Aquat. Toxicol. 132-133, 61-72 (2013
58. Ciolkowski M, Petersen JF, Ficker M, et al. Surface modification of PAMAM Dendrimer improves its biocompatibility. Nanomedicine. 8(6), 815-817 (2012
59. Kannan S, Dai H, Navath RS, et al. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit moDel. Sci. Transl. Med. 4(130), 130ra46 (2012
60. Xu L, Zhang H, Wu Y. Dendrimer advances for the central nervous system Delivery of therapeutics. ACS Chem. Neurosci. 5(1), 2-13 (2014
61. Perez-Carrion MD, Ceña V. Knocking down HMGB1 using Dendrimer-Delivered siRNA unveils its key role in NMDAinduced autophagy in rat cortical neurons. Pharm. Res. 30(10), 2584-2595 (2013
62. Patel SK, Gajbhiye V, Jain NK. Synthesis, characterization and brain targeting potential of paclitaxel loaDed thiamine-PPI nanoconjugates. J. Drug Target. 20(10), 841-849 (2012
63. Ke W, Shao K, Huang R, et al. Gene Delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycolmodified polyamidoamine Dendrimer. Biomaterials. 30(36), 6976-6985 (2009
64. Neelov IM, Janaszewska A, Klajnert B, et al. Molecular properties of lysine Dendrimers and their interactions with Abeta-peptiDes and neuronal cells. Curr. Med. Chem. 20(1), 134-143 (2013
65. Serramia MJ, Alvarez S, Fuentes-Paniagua E, et al. In vivo Delivery of siRNA to the brain by carbosilane Dendrimer. J. Control. Release 200, 60-70 (2015
66. Agrawal A, Min DH, Singh N, et al. Functional Delivery of siRNA in mice using Dendriworms. ACS Nano. 3(9), 2495-2504 (2009
67. Kim ID, Shin JH, Kim SW, et al. Intranasal Delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. Mol. Ther. 20(4), 829-839 (2012
68. Albertazzi L, Brondi M, Pavan GM, et al. Dendrimer-based fluorescent indicators: in vitro and in vivo applications. PLoS ONE. 6(12), e28450 (2011
69. Yan H, Wang J, Yi P, et al. Imaging brain tumor by Dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier. Chem. Commun. (Camb.) 47(28), 8130-8132 (2011
70. LebeDev AY, Cheprakov AV, Sakadzic S, Boas DA, Wilson DF, Vinogradov SA. Dendritic phosphorescent probes for oxygen imaging in biological systems. ACS Appl. Mater. Interfaces. 1(6), 1292-1304 (2009
71. Huang R, Han L, Li J, et al. Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis. Biomaterials. 32(22), 5177-5186 (2011
72. Yan H, Wang L, Wang J, et al. Two-orDer targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano. 6(1), 410-420 (2012
73. Matsumura S, Yuge R, Sato S, et al. Ultrastructural localization of intravenously injected carbon nanohorns in tumor. Int. J. Nanomed. 9, 3499-3508 (2014
74. Upadhyay RK. Drug Delivery systems, CNS protection, and the blood brain barrier. Biomed. Res. Int. 2014, 869269 (2014
75. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4(10), 627-633 (2009
76. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug Deliv. Rev. 58(14), 1460-1470 (2006
77. Li N, Zhao Q, Shu C, et al. Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug Delivery. Int. J. Pharm. 478(2), 644-654 (2015
78. Masserini M. Nanoparticles for brain drug Delivery. ISRN Biochem. 2013, 238428 (2013
79. Kafa H, Wang JT, Rubio N, et al. The interaction of carbon nanotubes with an in vitro blood-brain barrier moDel and mouse brain in vivo. Biomaterials 53, 437-452 (2015
80. Nunes A, Bussy C, Gherardini L, et al. In vivo Degradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex. Nanomed. (Lond.) 7(10), 1485-1494 (2012
81. Al-Jamal KT, Gherardini L, Bardi G, et al. Functional motor recovery from brain ischemic insult by carbon nanotubemediated siRNA silencing. Proc. Natl Acad. Sci. USA. 108(27), 10952-10957 (2011
82. Bardi G, Nunes A, Gherardini L, et al. Functionalized carbon nanotubes in the brain: cellular internalization and neuroinflammatory responses. PLoS ONE. 8(11), e80964 (2013
83. Kostarelos K, Lacerda L, Pastorin G, et al. Cellular uptake of functionalized carbon nanotubes is inDepenDent of functional group and cell type. Nat. Nanotechnol. 2(2), 108-113 (2007
84. Dubertret B, SkouriDes P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science. 298(5599), 1759-1762 (2002
85. Law WC, Mahajan SD, Kopwitthaya A, et al. Gene silencing of human neuronal cells for drug addiction therapy using anisotropic nanocrystals. Theranostics. 2(7), 695-704 (2012
86. Minami SS, Sun B, Popat K, et al. Selective targeting of microglia by quantum dots. J. Neuroinflamm. 9, 22 (2012
87. Boeneman K, Delehanty JB, Blanco-Canosa JB, et al. Selecting improved peptidyl motifs for cytosolic Delivery of disparate protein and nanoparticle materials. ACS Nano. 7(5), 3778-3796 (2013
88. Walters R, Kraig RP, Medintz I, et al. Nanoparticle targeting to neurons in a rat hippocampal slice culture moDel. ASN Neuro. 4(6), 383-392 (2012
89. Laurent S, Forge D, Port M, et al. Magnetic iron oxiDenanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108(6), 2064-2110 (2008
90. Thomsen LB, Linemann T, Pondman KM, et al. Uptake and transport of superparamagnetic iron oxiDenanoparticles through human brain capillary endothelial cells. ACS Chem. Neurosci. 4(10), 1352-1360 (2013
91. Sun Z, WorDen M, Wroczynskyj Y, et al. Magnetic field enhanced convective diffusion of iron oxiDenanoparticles in an osmotically disrupted cell culture moDel of the bloodbrain barrier. Int. J. Nanomed. 9, 3013-3026 (2014
92. Shevtsov MA, Nikolaev BP, Yakovleva LY, et al. Superparamagnetic iron oxiDenanoparticles conjugated with epiDermal growth factor (SPION-EGF) for targeting brain tumors. Int. J. Nanomed. 9, 273-287 (2014
93. Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxiDenanoparticles. Oncotarget. 6(11), 8788-8806 (2015
94. Fang JH, Lai YH, Chiu TL, Chen YY, Hu SH, Chen SY. Magnetic core-shell nanocapsules with dual-Targeting capabilities and co-Delivery of multiple drugs to treat brain gliomas. Adv. Healthc. Mater. 3(8), 1250-1260 (2014
95. Wang QB, Han Y, Jiang TT, et al. MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-Targeted ultrasmall superparamagnetic iron oxiDe. Eur. Radiol. 21(5), 1016-1025 (2011
96. Luchetti A, Milani D, Ruffini F, et al. Monoclonal antibodies conjugated with superparamagnetic iron oxiDeparticles allow magnetic resonance imaging Detection of lymphocytes in the mouse brain. Mol. Imaging. 11(2), 114-125 (2012
97. Wang YX. Superparamagnetic iron oxiDebased MRI contrast agents: current status of clinical application. Quant. Imaging Med. Surg. 1(1), 35-40 (2011
98. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, ModDer U, JanDer S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain. 127(Pt 7), 1670-1677 (2004
99. Etame AB, Diaz RJ, OReilly MA, et al. Enhanced Delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guiDed focused ultrasound. Nanomedicine. 8(7), 1133-1142 (2012
100. Dixit S, Novak T, Miller K, Zhu Y, Kenney ME, Broome AM. Transferrin receptor-Targeted theranostic gold nanoparticles for photosensitizer Delivery in brain tumors. Nanoscale. 7(5), 1782-1790 (2015
101. Cheng Y, Dai Q, Morshed RA, et al. Blood-brain barrier permeable gold nanoparticles: an efficient Delivery platform for enhanced malignant glioma therapy and imaging. Small. 10(24), 5137-5150 (2014
102. Liu Y, He M, Niu M, et al. Delivery of vincristine sulfateconjugated gold nanoparticles using liposomes: a lightresponsive nanocarrier with enhanced antitumor efficiency. Int. J. Nanomed. 10, 3081-3095 (2015
103. Ruan S, Yuan M, Zhang L, et al. Tumor microenvironment sensitive doxorubicin Delivery and release to glioma using angiopep-2 Decorated gold nanoparticles. Biomaterials 37, 425-435 (2015
104. Bobyk L, Edouard M, Deman P, et al. Photoactivation of gold nanoparticles for glioma treatment. Nanomedicine. 9(7), 1089-1097 (2013
105. Antosh MP, Wijesinghe DD, Shrestha S, et al. Enhancement of radiation effect on cancer cells by gold-pHLIP. Proc. Natl Acad. Sci. USA. 112(17), 5372-5376 (2015
106. Kouri FM, Hurley LA, Daniel WL, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 29(7), 732-745 (2015